18 June 2013
News | 15 January 2013
15, 2013 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company") announced today that it has adjourned its extraordinary general meeting of shareholders that was called to authorize and approve the ...
Click on the link to read the full article at NASDAQ
(This link will open in a new window)